DNAnexus Secures $15,000,000 Series B Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ee0a6f12-f622-4486-8644-28d677f3000d&Preview=1 -
Date
10/12/2011 -
Company Name
DNAnexus -
Mailing Address
420 Florence St. Palo Alto, CA 94301 -
Company Description
DNAnexus is a start-up in biocomputation aiming to transform the future of genetics, alter the course of medicine, help cure cancer! The advent of next-generation DNA sequencing technologies will soon enable one of the holy grails of medicine: the personal genome. -
Website
http://www.dnanexus.com -
Transaction Type
Venture Equity -
Transaction Amount
$15,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The new capital will help further DNAnexus’ mission to unlock the potential of DNA-based medicine and biotechnology by creating scalable and collaborative data technologies. The company intends to use the funds to expand hiring and accelerate product development. -
M&A Terms
-
Venture Investor
TPG Biotech -
Venture Investor
Google Ventures -
Venture Investor
SoftTech VC -
Venture Investor
K9 Ventures -
Venture Investor
First Round Capital -
Venture Investor
Felicis Ventures
